Cargando…
Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
BACKGROUND: Bladder cancer (BLCA) is a common urinary system malignancy with a significant morbidity and death rate worldwide. Non-muscle invasive BLCA accounts for over 75% of all BLCA cases. The imbalance of tumor metabolic pathways is associated with tumor formation and proliferation. Pyrimidine...
Autores principales: | Wu, Zixuan, Li, Xiaohuan, Gu, Zhenchang, Xia, Xinhua, Yang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470057/ https://www.ncbi.nlm.nih.gov/pubmed/37664033 http://dx.doi.org/10.3389/fonc.2023.1102518 |
Ejemplares similares
-
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
por: Wang, Wanyan, et al.
Publicado: (2021) -
Microenvironmental Targets in Sarcoma
por: Ehnman, Monika, et al.
Publicado: (2015) -
Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance
por: Zhou, Junying, et al.
Publicado: (2022) -
Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression
por: Di Carlo, Emma
Publicado: (2014) -
Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)